Literature DB >> 25873298

Contributing factors to the development of childhood asthma: working toward risk minimization.

George V Guibas1, Spyridon Megremis, Peter West, Nikolaos G Papadopoulos.   

Abstract

Asthma is the most common chronic disease in childhood, and considerable research has been undertaken to find ways to prevent its development and reduce its prevalence. For such interventions to be successful, risk factors for asthma emergence should be identified and clearly defined. Data are robust for some of them, including atopy, viral infections and exposure to airborne irritants, whereas it is less conclusive for others, such as aeroallergen exposure and bacterial infections. Several interventions for asthma prevention, including avoidance and pharmacotherapy, have been attempted. However, most of them have furnished equivocal results. Various issues hinder the establishment of risk factors for asthma development and reduce the effectiveness of interventions, including the complexity of the disease and the fluidity of the developing systems in childhood. In this review, we revisit the evidence on pediatric asthma risk factors and prevention and discuss issues that perplex this field.

Entities:  

Keywords:  asthma; avoidance; interventions; pharmacotherapy; prevention; risk factors

Mesh:

Substances:

Year:  2015        PMID: 25873298     DOI: 10.1586/1744666X.2015.1035649

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  1 in total

1.  Rhinovirus Species-Specific Antibodies Differentially Reflect Clinical Outcomes in Health and Asthma.

Authors:  Spyridon Megremis; Katarzyna Niespodziana; Clarissa Cabauatan; Paraskevi Xepapadaki; Marek L Kowalski; Tuomas Jartti; Claus Bachert; Susetta Finotto; Peter West; Sofia Stamataki; Anna Lewandowska-Polak; Heikki Lukkarinen; Nan Zhang; Theodor Zimmermann; Frank Stolz; Angela Neubauer; Mübeccel Akdis; Evangelos Andreakos; Rudolf Valenta; Nikolaos G Papadopoulos
Journal:  Am J Respir Crit Care Med       Date:  2018-12-15       Impact factor: 21.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.